Correlation Between 23Andme Holding and Cyclerion Therapeutics
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and Cyclerion Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and Cyclerion Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and Cyclerion Therapeutics, you can compare the effects of market volatilities on 23Andme Holding and Cyclerion Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of Cyclerion Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and Cyclerion Therapeutics.
Diversification Opportunities for 23Andme Holding and Cyclerion Therapeutics
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between 23Andme and Cyclerion is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and Cyclerion Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyclerion Therapeutics and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with Cyclerion Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyclerion Therapeutics has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and Cyclerion Therapeutics go up and down completely randomly.
Pair Corralation between 23Andme Holding and Cyclerion Therapeutics
Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to under-perform the Cyclerion Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, 23Andme Holding Co is 1.58 times less risky than Cyclerion Therapeutics. The stock trades about -0.07 of its potential returns per unit of risk. The Cyclerion Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 245.00 in Cyclerion Therapeutics on September 3, 2024 and sell it today you would lose (25.00) from holding Cyclerion Therapeutics or give up 10.2% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 99.6% |
| Values | Daily Returns |
23Andme Holding Co vs. Cyclerion Therapeutics
Performance |
| Timeline |
| 23Andme Holding |
| Cyclerion Therapeutics |
23Andme Holding and Cyclerion Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 23Andme Holding and Cyclerion Therapeutics
The main advantage of trading using opposite 23Andme Holding and Cyclerion Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, Cyclerion Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyclerion Therapeutics will offset losses from the drop in Cyclerion Therapeutics' long position.| 23Andme Holding vs. IDEXX Laboratories | 23Andme Holding vs. Twist Bioscience Corp | 23Andme Holding vs. Guardant Health | 23Andme Holding vs. Agilent Technologies |
| Cyclerion Therapeutics vs. Kronos Bio | Cyclerion Therapeutics vs. Larimar Therapeutics | Cyclerion Therapeutics vs. Addex Therapeutics | Cyclerion Therapeutics vs. Achilles Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |